Azitra, Inc. (NYSEAMERICAN:AZTR) Short Interest Down 79.8% in February

Azitra, Inc. (NYSEAMERICAN:AZTR) saw a large drop in short interest in February. As of February 27th, there was short interest totaling 123,961 shares, a drop of 79.8% from the February 12th total of 613,712 shares. Based on an average trading volume of 1,520,219 shares, the days-to-cover ratio is presently 0.1 days. Currently, 1.2% of the company’s stock are short sold. Currently, 1.2% of the company’s stock are short sold. Based on an average trading volume of 1,520,219 shares, the days-to-cover ratio is presently 0.1 days.

Azitra Trading Down 6.5%

NYSEAMERICAN:AZTR traded down $0.01 during mid-day trading on Wednesday, hitting $0.19. 1,183,754 shares of the company’s stock were exchanged, compared to its average volume of 1,694,587. Azitra has a one year low of $0.15 and a one year high of $2.66. The business has a fifty day moving average price of $0.24 and a 200 day moving average price of $0.45.

About Azitra

Azitra Inc is a clinical-stage biopharmaceutical company focused on developing live bacterial therapies for dermatological conditions. Headquartered in Cambridge, Massachusetts, the company leverages its proprietary ActoBiotic platform to formulate topical treatments that aim to modulate the skin’s native microbial ecosystem.

The company’s lead investigational therapies are being evaluated in early-phase clinical studies for inflammatory skin disorders, including atopic dermatitis and other conditions characterized by microbial imbalance.